Stakeholder focus group meeting on availability of lumpy skin disease (LSD) vaccines authorised to European Union (EU) standards

Date: 31/01/2017
Location: European Medicines Agency, London, UK

The purpose of the meeting is to review the current scientific knowledge and regulatory environment for the development of lumpy skin disease (LSD) vaccines following incursion of the disease in 2015 and to identify regulatory options to facilitate the development and authorisation of vaccines in accordance with EU standards. The focus group meeting is within the scope of the Heads of Medicines Agencies Network Strategy on availability for veterinary vaccines that aims to increase their availability by ensuring efficient and effective cooperation between all stakeholders.

Documents

How useful was this page?

Add your rating